TB Alliance Enters into Collaboration with sanofi-aventis to Fight Tuberculosis
The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration
News
Press Releases
News
Global Alliance for TB Drug Development Receives Pledge of up to $40 Million from USAID
The Global Alliance for TB Drug Development (TB Alliance), a public-private product-development partnership leading the development of new and affordable
News
Global Alliance for TB Drug Development Appoints Respected Scientist and Director of R&D as New Chief Executive
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
News
TB Alliance Appoints First Chief Administrative Officer
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
News
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D
The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a
News
Global Alliance for TB Drug Development Appoints Veteran Pharmaceutical Executive as New Chief Executive
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
News
GlaxoSmithKline and TB Alliance Renew Tuberculosis Drug Discovery Program
LONDON, UK and NEW YORK, January 24, 2008 – GlaxoSmithKline (GSK) and the Global Alliance for TB Drug Development (TB
News
TB Alliance Advances Two Drugs In Clinical Trials On Path To Faster, Better Tuberculosis Treatments
NEW YORK & CAPE TOWN, South Africa–The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership
News
Global Alliance for TB Drug Development CEO to Leave
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of
News
New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
New York – The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery